Tegatrabetan is primarily utilized in the field of medical research and therapeutic development. It is being investigated for its potential role in treating certain types of cancers, particularly those that are resistant to conventional therapies. Researchers are exploring its ability to modulate specific cellular pathways that are crucial for cancer cell survival and proliferation. Additionally, Tegatrabetan is being studied for its effects on neurodegenerative diseases, where it may help in slowing disease progression by targeting underlying pathological mechanisms. Its application in clinical trials aims to determine its efficacy and safety as a novel therapeutic agent.